Taro Iwatsubo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taro Iwatsubo has a total of 212 co-authors. Here are the top co-authors by number of shared publications:
Hiroki Nishikawa
Osaka Medical and Pharmaceutical University, Osaka Prefecture, Japan
17 shared publicationsAkitoshi Hakoda
Osaka Medical and Pharmaceutical University, Osaka Prefecture, Japan
11 shared publications- Kazuhiro Ota
Second Department of Internal Medicine Osaka Medical and Pharmaceutical University Osaka Japan
11 shared publications Shun Sasaki
Osaka Medical and Pharmaceutical University Hospital, Osaka Prefecture, Japan
11 shared publicationsKoji Higashino
Department of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan
10 shared publications- Noriya Uedo
Department of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan
10 shared publications
Latest Publications
- Open Access
- 11 October 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (10) , e70301
Rethinking Endoscopic Resection in Light of Sarcopenia
- 11 October 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (10) , e70301
Open AccessRethinking Endoscopic Resection in Light of Sarcopenia
- Open Access
- 1 October 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 05) , E1124-E1125
Cap-assisted photodynamic therapy for esophageal cancer: precise irradiation field control for tumor-confined treatment
- 1 October 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 05) , E1124-E1125
Open AccessCap-assisted photodynamic therapy for esophageal cancer: precise irradiation field control for tumor-confined treatment
- Open Access
Endoscopic Injection Sclerotherapy With Pre‐deflation Ligation for Prolonged Sclerosant Retention in Esophageal Varices: A Case Report
Esophageal varices are a common complication of portal hypertension, and prophylactic endoscopic injection sclerotherapy with ligation (EISL) is an established treatment option. Effective variceal thrombosis requires sufficient intravariceal retention of the sclerosant, because ethanolamine oleate exerts its thrombogenic effect through prolonged contact with the venous endothelium. In conventional EISL, endoscopic variceal ligation (EVL) is performed after balloon deflation, leaving a transient interval during which restored blood flow and an open puncture site may permit washout of the sclerosant and bleeding. We describe EIS with pre‐deflation ligation (EISpdL), in which EVL of the puncture site is completed while the endoscope balloon remains inflated, and balloon compression is maintained throughout the retention period. A 59‐year‐old man with medium‐sized esophageal varices with a positive red color sign (F2, RC1) secondary to metabolic dysfunction‐associated steatohepatitis underwent EISpdL combined with gel‐immersion EIS. The procedure was technically feasible, required no additional skills beyond conventional EISL, and no immediate procedure‐related adverse events were observed. Follow‐up endoscopy on post‐procedure day 7 showed bronze‐colored variceal changes indicating thrombosis, and contrast‐enhanced computed tomography two months later confirmed obliteration. EISpdL may enable more stable and prolonged sclerosant retention.
Open AccessEndoscopic Injection Sclerotherapy With Pre‐deflation Ligation for Prolonged Sclerosant Retention in Esophageal Varices: A Case Report
Esophageal varices are a common complication of portal hypertension, and prophylactic endoscopic injection sclerotherapy with ligation (EISL) is an established treatment option. Effective variceal thrombosis requires sufficient intravariceal retention of the sclerosant, because ethanolamine oleate exerts its thrombogenic effect through prolonged contact with the venous endothelium. In conventional EISL, endoscopic variceal ligation (EVL) is performed after balloon deflation, leaving a transient interval during which restored blood flow and an open puncture site may permit washout of the sclerosant and bleeding. We describe EIS with pre‐deflation ligation (EISpdL), in which EVL of the puncture site is completed while the endoscope balloon remains inflated, and balloon compression is maintained throughout the retention period. A 59‐year‐old man with medium‐sized esophageal varices with a positive red color sign (F2, RC1) secondary to metabolic dysfunction‐associated steatohepatitis underwent EISpdL combined with gel‐immersion EIS. The procedure was technically feasible, required no additional skills beyond conventional EISL, and no immediate procedure‐related adverse events were observed. Follow‐up endoscopy on post‐procedure day 7 showed bronze‐colored variceal changes indicating thrombosis, and contrast‐enhanced computed tomography two months later confirmed obliteration. EISpdL may enable more stable and prolonged sclerosant retention.
- 15 July 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (7) , e70206
Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan
Objectives: Postendoscopic submucosal dissection (ESD) bleeding remains a critical concern in patients receiving antithrombotic therapy, yet the risk after esophageal ESD is poorly characterized. This multicenter retrospective study evaluated the incidence of post‐ESD bleeding and thromboembolism in patients undergoing esophageal ESD while receiving antiplatelet therapy. Methods: We analyzed 570 patients with esophageal squamous cell carcinoma treated with ESD while on antiplatelet therapy between 2017 and 2022 at 21 institutions in Japan. Patients were categorized into guideline‐based discontinuation or continuation, excluding guideline‐deviating discontinuation. The primary endpoint was the rate of post‐ESD bleeding among thienopyridine users (monotherapy or dual antiplatelet therapy; DAPT) managed with guideline‐based discontinuation. Secondary endpoints included bleeding rates according to antiplatelet regimen and thromboembolism incidence. Results: A total of 154, 41, and 375 patients received thienopyridine monotherapy, DAPT, and aspirin monotherapy, respectively. Antiplatelet therapy was continued perioperatively in 32.5%, 31.7%, and 73.1% of these groups. Post‐ESD bleeding rates were 2.3% (3/132) and 3.2% (2/63) for guideline‐based discontinuation and continuation of thienopyridine users, respectively. Bleeding rates for discontinuation vs. continuation were 0% (0/101) vs. 0.7% (2/274) for aspirin monotherapy, 1.9% (2/104) vs. 4.0% (2/50) for thienopyridine monotherapy, and 3.6% (1/28) vs. 0% (0/13) for DAPT. Thromboembolism occurred in two patients, both receiving aspirin monotherapy. Conclusions: A substantial number of patients underwent esophageal ESD while continuing antiplatelet therapy. These descriptive findings suggest a need for further evaluation of continued therapy in larger studies.
- 15 July 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (7) , e70206
Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan
Objectives: Postendoscopic submucosal dissection (ESD) bleeding remains a critical concern in patients receiving antithrombotic therapy, yet the risk after esophageal ESD is poorly characterized. This multicenter retrospective study evaluated the incidence of post‐ESD bleeding and thromboembolism in patients undergoing esophageal ESD while receiving antiplatelet therapy. Methods: We analyzed 570 patients with esophageal squamous cell carcinoma treated with ESD while on antiplatelet therapy between 2017 and 2022 at 21 institutions in Japan. Patients were categorized into guideline‐based discontinuation or continuation, excluding guideline‐deviating discontinuation. The primary endpoint was the rate of post‐ESD bleeding among thienopyridine users (monotherapy or dual antiplatelet therapy; DAPT) managed with guideline‐based discontinuation. Secondary endpoints included bleeding rates according to antiplatelet regimen and thromboembolism incidence. Results: A total of 154, 41, and 375 patients received thienopyridine monotherapy, DAPT, and aspirin monotherapy, respectively. Antiplatelet therapy was continued perioperatively in 32.5%, 31.7%, and 73.1% of these groups. Post‐ESD bleeding rates were 2.3% (3/132) and 3.2% (2/63) for guideline‐based discontinuation and continuation of thienopyridine users, respectively. Bleeding rates for discontinuation vs. continuation were 0% (0/101) vs. 0.7% (2/274) for aspirin monotherapy, 1.9% (2/104) vs. 4.0% (2/50) for thienopyridine monotherapy, and 3.6% (1/28) vs. 0% (0/13) for DAPT. Thromboembolism occurred in two patients, both receiving aspirin monotherapy. Conclusions: A substantial number of patients underwent esophageal ESD while continuing antiplatelet therapy. These descriptive findings suggest a need for further evaluation of continued therapy in larger studies.
- Open Access
Clinicopathological Features of Superficial Non‐Ampullary Duodenal Epithelial Tumors Involving Brunner's Glands
Background and Aims: Although Brunner's glands (BGs), located in the submucosa of the duodenum, may be involved by tumor cells of superficial non‐ampullary duodenal epithelial tumors (SNADETs), the detailed incidence and histopathological features have not yet been analyzed. This study aimed to clarify the histopathological relationship between SNADETs and BGs. Methods: We retrospectively analyzed SNADETs that were resected at a single center between 2006 and 2021. Resected specimens were histologically evaluated to determine the presence and/or involvement of SNADET in BGs. The relationship between clinicopathological features and tumor involvement in BGs was also assessed. Results: In total, 114 lesions were included. Direct connection with BGs was seen in 52.6% of SNADETs, and submucosal BG involvement was observed in 7.0% (95% confidence interval 3.1%–13.4%) of SNADETs. The presence of submucosal BG involvement was significantly associated with 0‐IIc morphology, high‐grade dysplasia or carcinoma, and the gastric mucinous phenotype. The presence of either a lesion size 10 mm or greater or 0‐IIc morphology demonstrated a sensitivity of 100%, a specificity of 34.9%, and a false negative rate of 0% for predicting submucosal BG involvement. Moreover, non‐neoplastic BGs were exposed at the vertical margin in 15.1% of endoscopic resection specimens. Conclusion: SNADETs can have submucosal involvement via BGs, particularly in lesions fulfilling either a size ≥10 mm or a 0‐IIc morphology. These pathological findings suggest that vertical resectability may be relevant in their endoscopic management, although further studies are needed to clarify clinical implications.
Open AccessClinicopathological Features of Superficial Non‐Ampullary Duodenal Epithelial Tumors Involving Brunner's Glands
Background and Aims: Although Brunner's glands (BGs), located in the submucosa of the duodenum, may be involved by tumor cells of superficial non‐ampullary duodenal epithelial tumors (SNADETs), the detailed incidence and histopathological features have not yet been analyzed. This study aimed to clarify the histopathological relationship between SNADETs and BGs. Methods: We retrospectively analyzed SNADETs that were resected at a single center between 2006 and 2021. Resected specimens were histologically evaluated to determine the presence and/or involvement of SNADET in BGs. The relationship between clinicopathological features and tumor involvement in BGs was also assessed. Results: In total, 114 lesions were included. Direct connection with BGs was seen in 52.6% of SNADETs, and submucosal BG involvement was observed in 7.0% (95% confidence interval 3.1%–13.4%) of SNADETs. The presence of submucosal BG involvement was significantly associated with 0‐IIc morphology, high‐grade dysplasia or carcinoma, and the gastric mucinous phenotype. The presence of either a lesion size 10 mm or greater or 0‐IIc morphology demonstrated a sensitivity of 100%, a specificity of 34.9%, and a false negative rate of 0% for predicting submucosal BG involvement. Moreover, non‐neoplastic BGs were exposed at the vertical margin in 15.1% of endoscopic resection specimens. Conclusion: SNADETs can have submucosal involvement via BGs, particularly in lesions fulfilling either a size ≥10 mm or a 0‐IIc morphology. These pathological findings suggest that vertical resectability may be relevant in their endoscopic management, although further studies are needed to clarify clinical implications.
- Open Access
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1) , e70458
Small Bowel Obstruction Possibly Related to Migration of Trichobezoar Fragments Following Endoscopic Treatment
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1) , e70458
Open AccessSmall Bowel Obstruction Possibly Related to Migration of Trichobezoar Fragments Following Endoscopic Treatment
- Open Access
Geriatric 8 Score Predicts Functional Decline After Endoscopic Resection for Upper Gastrointestinal Neoplasms in Older Adults: A Prospective Cohort Study
Objectives: Endoscopic resection (ER) is used in older patients to treat upper gastrointestinal (UGI) neoplasms due to minimal invasiveness and excellent short‐term therapeutic outcomes. However, its impact on functional outcomes remains unclear. This study aimed to identify functional‐decline predictors post‐ER in older patients. Methods: This prospective, single‐center cohort study included patients aged ≥75 years undergoing ER for UGI neoplasms between April 2017 and December 2021. Cognitive and physical functions were assessed using the Mini‐Mental State Examination (MMSE) and Instrumental Activities of Daily Living (IADL) scales, before and 6–9 months post‐ER. Functional decline was defined as a decrease of ≥3 points in MMSE or ≥1 point in IADL. Scores of geriatric assessment tools, including the Geriatric 8 (G8), Vulnerable Elders Survey‐13 (VES‐13), Flemish Triage Risk Screening Tool, and Mini‐Cognitive Assessment Instrument (Mini‐Cog), were evaluated as potential functional‐decline predictors. Results: Of 202 patients, 37 (18.3%) experienced functional decline post‐ER. In multivariate analysis, poor G8 scores (≤14) were independent risk factors for functional decline (odds ratio: 2.64, 95% confidence interval: 1.02–6.84, p = 0.0461). Functional‐decline incidence gradually increased as G8 scores decreased ( p = 0.0086, trend test). Conclusions: Preoperative G8 scores may serve as functional‐decline predictors in older patients undergoing ER for UGI neoplasms. A preoperative G8 assessment could facilitate risk‐based treatment decisions from the perspective of functional outcomes in this vulnerable population.
Open AccessGeriatric 8 Score Predicts Functional Decline After Endoscopic Resection for Upper Gastrointestinal Neoplasms in Older Adults: A Prospective Cohort Study
Objectives: Endoscopic resection (ER) is used in older patients to treat upper gastrointestinal (UGI) neoplasms due to minimal invasiveness and excellent short‐term therapeutic outcomes. However, its impact on functional outcomes remains unclear. This study aimed to identify functional‐decline predictors post‐ER in older patients. Methods: This prospective, single‐center cohort study included patients aged ≥75 years undergoing ER for UGI neoplasms between April 2017 and December 2021. Cognitive and physical functions were assessed using the Mini‐Mental State Examination (MMSE) and Instrumental Activities of Daily Living (IADL) scales, before and 6–9 months post‐ER. Functional decline was defined as a decrease of ≥3 points in MMSE or ≥1 point in IADL. Scores of geriatric assessment tools, including the Geriatric 8 (G8), Vulnerable Elders Survey‐13 (VES‐13), Flemish Triage Risk Screening Tool, and Mini‐Cognitive Assessment Instrument (Mini‐Cog), were evaluated as potential functional‐decline predictors. Results: Of 202 patients, 37 (18.3%) experienced functional decline post‐ER. In multivariate analysis, poor G8 scores (≤14) were independent risk factors for functional decline (odds ratio: 2.64, 95% confidence interval: 1.02–6.84, p = 0.0461). Functional‐decline incidence gradually increased as G8 scores decreased ( p = 0.0086, trend test). Conclusions: Preoperative G8 scores may serve as functional‐decline predictors in older patients undergoing ER for UGI neoplasms. A preoperative G8 assessment could facilitate risk‐based treatment decisions from the perspective of functional outcomes in this vulnerable population.
- Open Access
Endoscopic Full‐thickness Resection for Gastric Submucosal Tumor: A Technical Analysis Study (With Video)
Background: Endoscopic full‐thickness resection (EFTR) is an effective treatment method for gastric submucosal tumors (SMTs). We aimed to perform a technical analysis of EFTR in gastric SMT and compare it with the outcome parameters. Method: Sixty‐one gastric SMTs from 60 patients were resected using EFTR. The indication criteria: size, 11–30 mm, connection to the muscularis propria on endoscopic ultrasonography, intraluminal growth type, no ulceration, and histologically evident or clinically suspicious gastrointestinal stromal tumors (GISTs). The following technical improvements were introduced during the study Periods 1–3: routine use of clip‐line traction (Periods 1–3); use of a plastic bag retriever (Periods 2–3); adaptation of the reopenable clip over‐the‐line method (ROLM, Period 3); implementation of no‐touch EFTR (Period 3); and elimination of submucosal injection (Period 3). Results: The endoscopic complete resection rate was 100%, with a similar tumor resection time (median, 50 min) throughout the periods. Specimen damage was less frequent after using the plastic bag retriever in Periods 2 and 3 ( p = 0.001). In Period 3, ROLM required longer full‐thickness defect closure time (39 min, p = 0.011), but it provided secure closure and shortened the fasting days ( p = 0.010). Histological diagnoses included 38 GISTs, 14 leiomyomas, and nine other pathologies. In Period 3, the implementation of no‐touch EFTR increased the resected specimen size (33 mm, p = 0.010) and improved the histological complete (R0) resection rate of the GISTs (13/13, 100%, p = 0.017). Conclusion: Several technical improvements significantly improved the outcomes of EFTR for gastric SMTs, warranting the external validation of this technique.
Open AccessEndoscopic Full‐thickness Resection for Gastric Submucosal Tumor: A Technical Analysis Study (With Video)
Background: Endoscopic full‐thickness resection (EFTR) is an effective treatment method for gastric submucosal tumors (SMTs). We aimed to perform a technical analysis of EFTR in gastric SMT and compare it with the outcome parameters. Method: Sixty‐one gastric SMTs from 60 patients were resected using EFTR. The indication criteria: size, 11–30 mm, connection to the muscularis propria on endoscopic ultrasonography, intraluminal growth type, no ulceration, and histologically evident or clinically suspicious gastrointestinal stromal tumors (GISTs). The following technical improvements were introduced during the study Periods 1–3: routine use of clip‐line traction (Periods 1–3); use of a plastic bag retriever (Periods 2–3); adaptation of the reopenable clip over‐the‐line method (ROLM, Period 3); implementation of no‐touch EFTR (Period 3); and elimination of submucosal injection (Period 3). Results: The endoscopic complete resection rate was 100%, with a similar tumor resection time (median, 50 min) throughout the periods. Specimen damage was less frequent after using the plastic bag retriever in Periods 2 and 3 ( p = 0.001). In Period 3, ROLM required longer full‐thickness defect closure time (39 min, p = 0.011), but it provided secure closure and shortened the fasting days ( p = 0.010). Histological diagnoses included 38 GISTs, 14 leiomyomas, and nine other pathologies. In Period 3, the implementation of no‐touch EFTR increased the resected specimen size (33 mm, p = 0.010) and improved the histological complete (R0) resection rate of the GISTs (13/13, 100%, p = 0.017). Conclusion: Several technical improvements significantly improved the outcomes of EFTR for gastric SMTs, warranting the external validation of this technique.
- Open Access
- 14 July 2025
- Published by SAGE Publications in Therapeutic Advances in Gastroenterology
- Vol. 18
Clinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute pancreatitis (Recover-AP study)
Background: If severe acute pancreatitis (SAP) is complicated by disseminated intravascular coagulation (DIC) or walled-off necrosis (WON), the mortality rate may increase. Therefore, prevention of the development of WON and treatment of DIC are likely to play important roles in improving survival in SAP. Although recombinant human soluble thrombomodulin (rhTM) might play a useful role in treating DIC, the impact of rhTM on improving survival and resolution of DIC due to SAP is still unclear. Objective: This study aimed to evaluate the clinical impact of rhTM in patients with SAP and DIC. Design: A single-center retrospective study. Method: The patients were divided into two groups: the rhTM group and the non-rhTM group, in which rhTM was not administered. The primary outcome was the DIC resolution rate at 7 days after starting treatment. The mortality rate at 28 days was secondarily evaluated. Results: Among 321 SAP patients, 63 patients were complicated with DIC, and they were divided into rhTM ( n = 28) and non-rhTM ( n = 35) groups. The rate of development of WON was significantly higher in the non-rhTM group (51.4%, 18/35) compared with the rhTM group (25.0%, 7/28) ( p = 0.033). The resolution rate of DIC within 7 days was significantly higher in the rhTM group (89.3%, 25/28) compared with the non-rhTM group (60.0%, n = 9/35) ( p = 0.009). The mortality rate within 14 days, which might have been strongly influenced by the presence of DIC, was significantly higher in the non-rhTM group (20.0%, 7/35) compared with the rhTM group (0%, 0/28) ( p = 0.01). According to multivariate analysis, rTM non-administration was an independent factor for failed DIC resolution or developing WON. Conclusion: In conclusion, rhTM may play a role not only in improving the resolution rate of DIC and improving the survival rate of SAP, but also in preventing the development of WON.
- 14 July 2025
- Published by SAGE Publications in Therapeutic Advances in Gastroenterology
- Vol. 18
Open AccessClinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute pancreatitis (Recover-AP study)
Background: If severe acute pancreatitis (SAP) is complicated by disseminated intravascular coagulation (DIC) or walled-off necrosis (WON), the mortality rate may increase. Therefore, prevention of the development of WON and treatment of DIC are likely to play important roles in improving survival in SAP. Although recombinant human soluble thrombomodulin (rhTM) might play a useful role in treating DIC, the impact of rhTM on improving survival and resolution of DIC due to SAP is still unclear. Objective: This study aimed to evaluate the clinical impact of rhTM in patients with SAP and DIC. Design: A single-center retrospective study. Method: The patients were divided into two groups: the rhTM group and the non-rhTM group, in which rhTM was not administered. The primary outcome was the DIC resolution rate at 7 days after starting treatment. The mortality rate at 28 days was secondarily evaluated. Results: Among 321 SAP patients, 63 patients were complicated with DIC, and they were divided into rhTM ( n = 28) and non-rhTM ( n = 35) groups. The rate of development of WON was significantly higher in the non-rhTM group (51.4%, 18/35) compared with the rhTM group (25.0%, 7/28) ( p = 0.033). The resolution rate of DIC within 7 days was significantly higher in the rhTM group (89.3%, 25/28) compared with the non-rhTM group (60.0%, n = 9/35) ( p = 0.009). The mortality rate within 14 days, which might have been strongly influenced by the presence of DIC, was significantly higher in the non-rhTM group (20.0%, 7/35) compared with the rhTM group (0%, 0/28) ( p = 0.01). According to multivariate analysis, rTM non-administration was an independent factor for failed DIC resolution or developing WON. Conclusion: In conclusion, rhTM may play a role not only in improving the resolution rate of DIC and improving the survival rate of SAP, but also in preventing the development of WON.
- Open Access
Successful perforation management during esophageal endoscopic submucosal dissection using the stent‐anchoring method: A case report
Patients with esophageal endoscopic submucosal dissection‐associated adverse events can have a severe clinical course. In this report, we describe the case of a 67‐year‐old male with a history of endoscopic submucosal dissection who had metachronous superficial esophageal cancer. Although endoscopic submucosal dissection was attempted for challenging lesions adjacent to the scar, perforations occurred during the procedure. We placed an esophageal fully covered self‐expandable metallic stent at the perforation site to avoid emergency surgery after lesion removal. However, stent migration and displacement concerns remained, as no stenosis was observed in the esophagus. Therefore, a clip with a thread on the upper edge of the stent was placed, and this anchoring clip was useful in preventing stent migration and closing the perforation. The patient improved with conservative treatment. In conclusion, the stent placement and anchoring method with clip and thread could be a treatment option in such cases.
Open AccessSuccessful perforation management during esophageal endoscopic submucosal dissection using the stent‐anchoring method: A case report
Patients with esophageal endoscopic submucosal dissection‐associated adverse events can have a severe clinical course. In this report, we describe the case of a 67‐year‐old male with a history of endoscopic submucosal dissection who had metachronous superficial esophageal cancer. Although endoscopic submucosal dissection was attempted for challenging lesions adjacent to the scar, perforations occurred during the procedure. We placed an esophageal fully covered self‐expandable metallic stent at the perforation site to avoid emergency surgery after lesion removal. However, stent migration and displacement concerns remained, as no stenosis was observed in the esophagus. Therefore, a clip with a thread on the upper edge of the stent was placed, and this anchoring clip was useful in preventing stent migration and closing the perforation. The patient improved with conservative treatment. In conclusion, the stent placement and anchoring method with clip and thread could be a treatment option in such cases.